Previous Close | 0.0550 |
Open | 0.0550 |
Bid | 0.0500 x N/A |
Ask | 0.0550 x N/A |
Day's Range | 0.0500 - 0.0550 |
52 Week Range | 0.0400 - 0.1250 |
Volume | |
Avg. Volume | 136,581 |
Market Cap | 22.174M |
Beta (5Y Monthly) | 1.68 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.0400 |
Earnings Date | Mar 29, 2023 - Apr 01, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.15 |
2nd consecutive quarter of positive Adjusted EBITDA14% Adjusted EBITDA margin2 places company in top 3 position for profitability amongst its peers39% growth in adult use revenue4 over prior quarter; 5% growth in adult-use revenue5 year over year40% increase in medical net revenue6 with $1.1 million record month revenue in November 20221st shipment made toward new European agreement announced in Q2 FY2023Estimated $1 million sales7 contract to second European partner Gross profit before fair val
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) will now announce on Monday, February 13 prior to market open its fiscal year 2023 third quarter results for the period ending December 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale. CONFERENCE CALL & WEBCASTDate: February 13, 2023Time: 8:30 a.m. EST To view the